Clinically, breast cancer is heterogeneous and divided into three major subtypes: estrogen receptor (ER)–positive and progesterone receptor (PR)–positive, human epidermal growth factor receptor-2+ and triple-negative breast cancer (TNBC).3 Here, ERBB2 is linked to breast carcinoma.